PAR 1.64% 31.0¢ paradigm biopharmaceuticals limited..

PAR and BMEL % of OA

  1. 4,229 Posts.
    lightbulb Created with Sketch. 6703
    Paradigmers, Ok in all my reading and re-reading I occasionally have to double take...I mean I read something and don't really take it in until the second (read; third) time! I was reading 51 Cap's report titled "Getting the answers before the test" and I came across the part where they talk about the patents and how due to the brilliance of PAR management they have locked up and prevented other competitors from coming up with their own version of iPPS to treat BMEL associated with OA.

    Now get this, perhaps in my naivety, I always thought BMEL associated with OA was around 20% perhaps a bit more. Not so.
    51 CAP state "nearly all OA has some level of BME present". Ok we need a definitive scientific source, "Nearly All" isn't too specific for me or for you so lets check on this please Mr Mozzarc...

    According to the highly respected NCBI3 (National Centre for Biotechnology which is part of the National Library of Medicine in the US), have a look at the percentage for yourself.

    https://hotcopper.com.au/data/attachments/1719/1719136-a6277aa2ae11e561592c6903f63516a8.jpg


    This is why we are going to be successful....a massive 66% was found of the 109 subjects that had OA, had BML. That's higher than I realised and why so many people are going to be amazed but what we have. For you new guys that are scratching their heads wondering what all my fuss is about, iPPS works best with patients with BML conditions, that's our focus....My opinions, I'm not a doc, I'm not a scientist, please do your own research and find out for yourself. I'm very positive and enthusiastic, I have a vested interest so you need to DYOR. Tip of iceberg comes to mind...


    https://hotcopper.com.au/data/attachments/1719/1719134-cc4da95c0643db95e418b4b679243288.jpg
    Most outsiders, if anything, just see a tiny part of the PAR ice for the moment...wait till they find out what's beneath the surface..



    REFERENCES
    1) https://www.verywellhealth.com/what-is-bone-marrow-edema-2552132
    2) 51 Capital
    3) https://www.ncbi.nlm.nih.gov/pubmed/20823092

    Last edited by Mozzarc: 08/09/19
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.005(1.64%)
Mkt cap ! $108.4M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $98.05K 323.7K

Buyers (Bids)

No. Vol. Price($)
1 29159 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.